RTC: The Effectiveness of Regular Exercise on Improving Sleep in Older Adults

Sponsor
Stanford University (Other)
Overall Status
Completed
CT.gov ID
NCT00149747
Collaborator
National Institute of Mental Health (NIMH) (NIH)
66
1
2
49
1.3

Study Details

Study Description

Brief Summary

This study will evaluate the effect of regular aerobic exercise on improving sleep in older adults with moderate difficulty sleeping.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Moderate-Intensity Aerobic Physical Activity
  • Behavioral: Health Education Class
Phase 2/Phase 3

Detailed Description

Sleep deprivation is a common problem among older adults. It is often at the root of increased mortality and some psychiatric disorders. Regular participation in a medium-intensity exercise regimen may help people sleep better. This study will assess the effectiveness of a regular exercise program on improving sleep in older adults with moderate difficulty sleeping.

Participants will be randomly assigned to one of two conditions. One group will partake in a moderate-intensity physical activity training regimen. The other group will act as a non-exercise attention-control comparison group. Each group will undergo its assigned treatment for 12 months. Sleep quantity and quality will be measured objectively using in-home polysomnography. Subjective sleep quality and health-related quality of life measures will be evaluated with questionnaires. All measurements will be performed at the beginning of the study, Month 6, and Month 12.

Study Design

Study Type:
Interventional
Actual Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Promoting Exercise, Sleep and Well-Being in Older Adults
Study Start Date :
Aug 1, 1999
Actual Primary Completion Date :
Sep 1, 2003
Actual Study Completion Date :
Sep 1, 2003

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exercise training

Group based exercise training. Two weekly classes including aerobic endurance physical activity and strength and flexibility training, and up to three home-based sessions of similar composition of aerobic endurance, strength and flexibility training.

Behavioral: Moderate-Intensity Aerobic Physical Activity
Moderate-Intensity Aerobic Physical Activity. 4+ days per week, 60+ minutes per day, moderate or greater intensity physical activity
Other Names:
  • Comprehensive fitness class
  • Placebo Comparator: 2

    Attention-control of exposure to study staff. Weekly general health education classes conducted in group sessions.

    Behavioral: Health Education Class
    2 classes a week, 90+minutes per class, general health education, excluding information on physical activity
    Other Names:
  • Healthy Aging Workshops
  • Outcome Measures

    Primary Outcome Measures

    1. % Time in Stage 2 Sleep at 12 Months, Adjusted for Baseline [baseline, 12 months]

      Percent of total sleep time spent in Stage 2 sleep at 12 months after adjusting for baseline level of Stage 2 sleep (i.e., baseline value included as a covariate in regression models conducted).

    Secondary Outcome Measures

    1. Sleep Disturbances [12 months]

      Self-reported sleep disturbance subscale on Pittsburgh Sleep Quality Index Subscale consists of 9 items scored on a range of 0 to 3, 0 indicating no disturbance and 3 indicating frequent disturbance. All 9 items are summed, and the summary scores is captured by 1 of 4 categories ranging from 0 to 3, with 0 indicating less frequent disturbances and 3 indicating greater frequency of disturbances.

    2. Peak Exercise Oxygen Consumption [12 months]

      Peak oxygen consumption measured during symptom limited treadmill exercise stress test

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    55 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Moderate difficulty sleeping unrelated to a physical illness or psychopathology (determined by the Sleep Questionnaire and Assessment of Wakefulness)

    • Currently not physically active on a regular basis

    • Body mass index less than 38

    Exclusion Criteria:
    • Currently physically active on a regular basis

    • Diagnosed with a clinically significant sleep disorder

    • Mild or no sleep complaints (determined by the Sleep Questionnaire and Assessment of Wakefulness)

    • Unstable on medications

    • Current smoker

    • Consumes more than three alcoholic beverages per day

    • Medical condition that may limit participation in moderate-intensity exercise

    • Diagnosed with clinical psychopathology

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Stanford Prevention Research Center Stanford California United States 94305-5705

    Sponsors and Collaborators

    • Stanford University
    • National Institute of Mental Health (NIMH)

    Investigators

    • Principal Investigator: Abby C King, PhD, Stanford University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Abby C King, Professor, Stanford University
    ClinicalTrials.gov Identifier:
    NCT00149747
    Other Study ID Numbers:
    • R01MH058853
    • R01MH058853
    • DAHBR HB-C
    First Posted:
    Sep 8, 2005
    Last Update Posted:
    May 24, 2016
    Last Verified:
    Apr 1, 2016
    Keywords provided by Abby C King, Professor, Stanford University
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details Participants recruited through radio and newspaper advertisement, direct mailings to local addresses.
    Pre-assignment Detail Overnight pulse oximetry for 1 night to rule out sleep apnea
    Arm/Group Title Exercise Group Attention-Control (Health Education) Group
    Arm/Group Description Regular, aerobic endurance physical activity Moderate-Intensity Aerobic Physical Activity : 4+ days per week, 60+ minutes per day, moderate or greater intensity physical activity Weekly general health education classes Health Education Class : 2 classes a week, 90+minutes per class, general health education, excluding information on physical activity
    Period Title: Overall Study
    STARTED 36 30
    COMPLETED 32 27
    NOT COMPLETED 4 3

    Baseline Characteristics

    Arm/Group Title Exercise Group Attention-Control (Health Education) Group Total
    Arm/Group Description Regular, aerobic endurance physical activity Moderate-Intensity Aerobic Physical Activity : 4+ days per week, 60+ minutes per day, moderate or greater intensity physical activity Weekly general health education classes Health Education Class : 2 classes a week, 90+minutes per class, general health education, excluding information on physical activity Total of all reporting groups
    Overall Participants 36 30 66
    Age (Count of Participants)
    <=18 years
    0
    0%
    0
    0%
    0
    0%
    Between 18 and 65 years
    36
    100%
    30
    100%
    66
    100%
    >=65 years
    0
    0%
    0
    0%
    0
    0%
    Sex: Female, Male (Count of Participants)
    Female
    24
    66.7%
    20
    66.7%
    44
    66.7%
    Male
    12
    33.3%
    10
    33.3%
    22
    33.3%

    Outcome Measures

    1. Primary Outcome
    Title % Time in Stage 2 Sleep at 12 Months, Adjusted for Baseline
    Description Percent of total sleep time spent in Stage 2 sleep at 12 months after adjusting for baseline level of Stage 2 sleep (i.e., baseline value included as a covariate in regression models conducted).
    Time Frame baseline, 12 months

    Outcome Measure Data

    Analysis Population Description
    Intent to Treat
    Arm/Group Title Exercise Group Attention-Control (Health Education) Group
    Arm/Group Description Regular, aerobic endurance physical activity Moderate-Intensity Aerobic Physical Activity : 4+ days per week, 60+ minutes per day, moderate or greater intensity physical activity Weekly general health education classes Health Education Class : 2 classes a week, 90+minutes per class, general health education, excluding information on physical activity
    Measure Participants 35 30
    Mean (Standard Deviation) [percentage of sleep time]
    53.7
    (9.6)
    51.0
    (9.8)
    2. Secondary Outcome
    Title Sleep Disturbances
    Description Self-reported sleep disturbance subscale on Pittsburgh Sleep Quality Index Subscale consists of 9 items scored on a range of 0 to 3, 0 indicating no disturbance and 3 indicating frequent disturbance. All 9 items are summed, and the summary scores is captured by 1 of 4 categories ranging from 0 to 3, with 0 indicating less frequent disturbances and 3 indicating greater frequency of disturbances.
    Time Frame 12 months

    Outcome Measure Data

    Analysis Population Description
    Intent to treat
    Arm/Group Title Exercise Group Attention-Control (Health Education) Group
    Arm/Group Description Regular, aerobic endurance physical activity Moderate-Intensity Aerobic Physical Activity : 4+ days per week, 60+ minutes per day, moderate or greater intensity physical activity Weekly general health education classes Health Education Class : 2 classes a week, 90+minutes per class, general health education, excluding information on physical activity
    Measure Participants 35 30
    Mean (Standard Deviation) [units on a scale]
    1.3
    (.47)
    1.6
    (.5)
    3. Secondary Outcome
    Title Peak Exercise Oxygen Consumption
    Description Peak oxygen consumption measured during symptom limited treadmill exercise stress test
    Time Frame 12 months

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Exercise Group Attention-Control (Health Education) Group
    Arm/Group Description Regular, aerobic endurance physical activity Moderate-Intensity Aerobic Physical Activity : 4+ days per week, 60+ minutes per day, moderate or greater intensity physical activity Weekly general health education classes Health Education Class : 2 classes a week, 90+minutes per class, general health education, excluding information on physical activity
    Measure Participants 35 30
    Mean (Standard Deviation) [mL of 02 per Kg per minute]
    24.7
    (2.2)
    23.1
    (2.3)

    Adverse Events

    Time Frame Adverse events were collected over a 4-year period
    Adverse Event Reporting Description Adverse events were collected by blinded study staff during scheduled clinical measurements (baseline, 6month and 12 month)
    Arm/Group Title Exercise Group Attention-Control (Health Education) Group
    Arm/Group Description Regular, aerobic endurance physical activity Moderate-Intensity Aerobic Physical Activity : 4+ days per week, 60+ minutes per day, moderate or greater intensity physical activity Weekly general health education classes Health Education Class : 2 classes a week, 90+minutes per class, general health education, excluding information on physical activity
    All Cause Mortality
    Exercise Group Attention-Control (Health Education) Group
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN)
    Serious Adverse Events
    Exercise Group Attention-Control (Health Education) Group
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/36 (0%) 0/30 (0%)
    Other (Not Including Serious) Adverse Events
    Exercise Group Attention-Control (Health Education) Group
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/36 (0%) 0/30 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Abby C. King
    Organization Stanford Prevention Research Center
    Phone 6507252826
    Email king@stanford.edu
    Responsible Party:
    Abby C King, Professor, Stanford University
    ClinicalTrials.gov Identifier:
    NCT00149747
    Other Study ID Numbers:
    • R01MH058853
    • R01MH058853
    • DAHBR HB-C
    First Posted:
    Sep 8, 2005
    Last Update Posted:
    May 24, 2016
    Last Verified:
    Apr 1, 2016